Leading TechBio Investment Firm ARTIS Ventures Announces 2023 Class of Healthcare and Life Sciences Fellows
12 janv. 2024 12h00 HE
|
ARTIS Ventures
San Francisco, CA, Jan. 12, 2024 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. Selected from...
Delivering Next Generation Addiction Recovery, Affect Therapeutics Raises $16 Million in Series A Funding Led by ARTIS Ventures
12 juil. 2023 07h00 HE
|
ARTIS Ventures
McLean, VA, July 12, 2023 (GLOBE NEWSWIRE) -- Affect Therapeutics (“Affect”), a company reimagining addiction treatment for the digital age, today announces a $16 million Series A led by...
With the Potential to Revolutionize Personalized Health, Range Biotechnologies Receives $5.2 Million in Seed Funding Led by TechBio-Focused ARTIS Ventures
12 juin 2023 11h00 HE
|
ARTIS Ventures
San Francisco, CA, June 12, 2023 (GLOBE NEWSWIRE) -- Range Biotechnologies (“Range Bio”), a proteomics-focused biotech company that has developed an innovative translational platform to enable...
Leading TechBio Investment Firm ARTIS Ventures Announces 2022 Class of Healthcare and Life Sciences Fellows
14 déc. 2022 11h00 HE
|
ARTIS Ventures
San Francisco , Dec. 14, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced its newest class of AV Fellows. The 2022 fellows...
ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team
10 oct. 2022 11h00 HE
|
ARTIS Ventures
San Francisco, Oct. 10, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced Henry Klingenstein has joined the investment...
ARTIS Ventures Promotes Ameena El-Bibany to Partner
15 déc. 2021 10h40 HE
|
ARTIS Ventures
San Francisco, CA, Dec. 15, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures, a San Francisco-based venture firm focused on pioneering investments at the intersection of life sciences and computer sciences,...
ARTIS Ventures Announces 2021 Class of Healthcare and Life Sciences Fellows
03 août 2021 13h13 HE
|
ARTIS Ventures
San Francisco, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- ARTIS Ventures (“AV”), a venture firm focused on pioneering investments in biotech, health, and life sciences, today announced the candidates...
Creating Next Generation Smart Cell Therapies: Outpace Bio Receives $30 Million in Series A Funding Led by ARTIS Ventures and Lyell Immunopharma Inc.
31 mars 2021 09h00 HE
|
ARTIS Ventures
Seattle, WA, March 31, 2021 (GLOBE NEWSWIRE) -- Outpace Bio, a biotechnology company building a platform to create next-generation smart cell therapies, today announced the closing of a $30 million...
Second Front Systems Raises $6 Million to Provide Immediate Impact to National Security, led by ARTIS Ventures
07 juil. 2020 11h00 HE
|
ARTIS Ventures
San Francisco, CA, July 07, 2020 (GLOBE NEWSWIRE) -- Second Front Systems, a software company working to disrupt the traditional aerospace and defense industry by acting as a beachhead for...
ARTIS Ventures Welcomes Jeff Kindler as Operating Partner
20 avr. 2020 12h00 HE
|
ARTIS Ventures
SAN FRANCISCO, April 20, 2020 (GLOBE NEWSWIRE) -- ARTIS Ventures, a venture firm focused on pioneering investments at the intersection of life sciences and computer sciences, today announced that...